Early assessment of chemotherapy response in advanced non-small cell lung cancer with circulating tumor DNA
Monitoring treatment efficacy early during therapy could enable a change in treatment to improve patient outcomes. We report an early assessment of response to treatment in advanced NSCLC using a plasma-only strategy to measure changes in ctDNA levels after one cycle of chemotherapy. Plasma samples...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2022
|
| In: |
Cancers
Year: 2022, Jahrgang: 14, Heft: 10, Pages: 1-14 |
| ISSN: | 2072-6694 |
| DOI: | 10.3390/cancers14102479 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers14102479 Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6694/14/10/2479 
|
| Verfasserangaben: | Stephanie J. Yaung, Corinna Woestmann, Christine Ju, Xiaoju Max Ma, Sandeep Gattam, Yiyong Zhou, Liu Xi, Subrata Pal, Aarthi Balasubramanyam, Nalin Tikoo, Claus Peter Heussel, Michael Thomas, Mark Kriegsmann, Michael Meister, Marc A. Schneider, Felix J. Herth, Birgit Wehnl, Maximilian Diehn, Ash A. Alizadeh, John F. Palma and Thomas Muley |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1809476496 | ||
| 003 | DE-627 | ||
| 005 | 20220820220131.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220708s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/cancers14102479 |2 doi | |
| 035 | |a (DE-627)1809476496 | ||
| 035 | |a (DE-599)KXP1809476496 | ||
| 035 | |a (OCoLC)1341463590 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Yaung, Stephanie |e VerfasserIn |0 (DE-588)1262091500 |0 (DE-627)1809474825 |4 aut | |
| 245 | 1 | 0 | |a Early assessment of chemotherapy response in advanced non-small cell lung cancer with circulating tumor DNA |c Stephanie J. Yaung, Corinna Woestmann, Christine Ju, Xiaoju Max Ma, Sandeep Gattam, Yiyong Zhou, Liu Xi, Subrata Pal, Aarthi Balasubramanyam, Nalin Tikoo, Claus Peter Heussel, Michael Thomas, Mark Kriegsmann, Michael Meister, Marc A. Schneider, Felix J. Herth, Birgit Wehnl, Maximilian Diehn, Ash A. Alizadeh, John F. Palma and Thomas Muley |
| 264 | 1 | |c 2022 | |
| 300 | |a 14 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published: 18 May 2022 | ||
| 500 | |a This article belongs to the Special Issue Cell-Free DNA as Prognostic and Predictive Biomarker in Solid Cancers | ||
| 500 | |a Gesehen am 08.07.2022 | ||
| 520 | |a Monitoring treatment efficacy early during therapy could enable a change in treatment to improve patient outcomes. We report an early assessment of response to treatment in advanced NSCLC using a plasma-only strategy to measure changes in ctDNA levels after one cycle of chemotherapy. Plasma samples were collected from 92 patients with Stage IIIB-IV NSCLC treated with first-line chemo- or chemoradiation therapies in an observational, prospective study. Retrospective ctDNA analysis was performed using next-generation sequencing with a targeted 198-kb panel designed for lung cancer surveillance and monitoring. We assessed whether changes in ctDNA levels after one or two cycles of treatment were associated with clinical outcomes. Subjects with ≤50% decrease in ctDNA level after one cycle of chemotherapy had a lower 6-month progression-free survival rate (33% vs. 58%, HR 2.3, 95% CI 1.2 to 4.2, log-rank p = 0.009) and a lower 12-month overall survival rate (25% vs. 70%, HR 4.3, 95% CI 2.2 to 9.7, log-rank p < 0.001). Subjects with ≤50% decrease in ctDNA level after two cycles of chemotherapy also had shorter survival. Using non-invasive liquid biopsies to measure early changes in ctDNA levels in response to chemotherapy may help identify non-responders before standard-of-care imaging in advanced NSCLC. | ||
| 650 | 4 | |a chemotherapy | |
| 650 | 4 | |a ctDNA | |
| 650 | 4 | |a early molecular response | |
| 650 | 4 | |a NGS | |
| 650 | 4 | |a NSCLC | |
| 700 | 1 | |a Woestmann, Corinna |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ju, Christine |e VerfasserIn |4 aut | |
| 700 | 1 | |a Ma, Xiaoju Max |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gattam, Sandeep |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zhou, Yiyong |e VerfasserIn |4 aut | |
| 700 | 1 | |a Xi, Liu |e VerfasserIn |4 aut | |
| 700 | 1 | |a Pal, Subrata |e VerfasserIn |4 aut | |
| 700 | 1 | |a Balasubramanyam, Aarthi |e VerfasserIn |4 aut | |
| 700 | 1 | |a Tikoo, Nalin |e VerfasserIn |4 aut | |
| 700 | 1 | |a Heußel, Claus Peter |e VerfasserIn |0 (DE-588)1048631389 |0 (DE-627)780769422 |0 (DE-576)40288146X |4 aut | |
| 700 | 1 | |a Thomas, Michael |e VerfasserIn |0 (DE-588)1054438781 |0 (DE-627)79152213X |0 (DE-576)41027089X |4 aut | |
| 700 | 1 | |a Kriegsmann, Mark |d 1987- |e VerfasserIn |0 (DE-588)103740324X |0 (DE-627)755668782 |0 (DE-576)39141870X |4 aut | |
| 700 | 1 | |a Meister, Michael |e VerfasserIn |0 (DE-588)1078792046 |0 (DE-627)839461402 |0 (DE-576)451890108 |4 aut | |
| 700 | 1 | |a Schneider, Marc |d 1982- |e VerfasserIn |0 (DE-588)140634401 |0 (DE-627)620239948 |0 (DE-576)319208095 |4 aut | |
| 700 | 1 | |a Herth, Felix |e VerfasserIn |0 (DE-588)1016095236 |0 (DE-627)705477568 |0 (DE-576)351509925 |4 aut | |
| 700 | 1 | |a Wehnl, Birgit |e VerfasserIn |4 aut | |
| 700 | 1 | |a Diehn, Maximilian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Alizadeh, Ash A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Palma, John F. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Muley, Thomas |e VerfasserIn |0 (DE-588)1056885432 |0 (DE-627)794179169 |0 (DE-576)16759284X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cancers |d Basel : MDPI, 2009 |g 14(2022), 10, Artikel-ID 2479, Seite 1-14 |h Online-Ressource |w (DE-627)614095670 |w (DE-600)2527080-1 |w (DE-576)313958548 |x 2072-6694 |7 nnas |a Early assessment of chemotherapy response in advanced non-small cell lung cancer with circulating tumor DNA |
| 773 | 1 | 8 | |g volume:14 |g year:2022 |g number:10 |g elocationid:2479 |g pages:1-14 |g extent:14 |a Early assessment of chemotherapy response in advanced non-small cell lung cancer with circulating tumor DNA |
| 856 | 4 | 0 | |u https://doi.org/10.3390/cancers14102479 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.mdpi.com/2072-6694/14/10/2479 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220708 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 1056885432 |a Muley, Thomas |m 1056885432:Muley, Thomas |d 910000 |d 950000 |d 950900 |e 910000PM1056885432 |e 950000PM1056885432 |e 950900PM1056885432 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 21 |y j | ||
| 998 | |g 1016095236 |a Herth, Felix |m 1016095236:Herth, Felix |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PH1016095236 |e 950000PH1016095236 |e 950900PH1016095236 |e 50000PH1016095236 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 16 | ||
| 998 | |g 140634401 |a Schneider, Marc |m 140634401:Schneider, Marc |d 910000 |d 950000 |d 950900 |e 910000PS140634401 |e 950000PS140634401 |e 950900PS140634401 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 15 | ||
| 998 | |g 1078792046 |a Meister, Michael |m 1078792046:Meister, Michael |d 910000 |d 950000 |d 950900 |e 910000PM1078792046 |e 950000PM1078792046 |e 950900PM1078792046 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 14 | ||
| 998 | |g 103740324X |a Kriegsmann, Mark |m 103740324X:Kriegsmann, Mark |d 910000 |d 912000 |d 50000 |e 910000PK103740324X |e 912000PK103740324X |e 50000PK103740324X |k 0/910000/ |k 1/910000/912000/ |k 0/50000/ |p 13 | ||
| 998 | |g 1054438781 |a Thomas, Michael |m 1054438781:Thomas, Michael |d 910000 |d 950000 |d 950900 |d 50000 |e 910000PT1054438781 |e 950000PT1054438781 |e 950900PT1054438781 |e 50000PT1054438781 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |k 0/50000/ |p 12 | ||
| 998 | |g 1048631389 |a Heußel, Claus Peter |m 1048631389:Heußel, Claus Peter |d 910000 |d 950000 |d 950900 |e 910000PH1048631389 |e 950000PH1048631389 |e 950900PH1048631389 |k 0/910000/ |k 1/910000/950000/ |k 2/910000/950000/950900/ |p 11 | ||
| 999 | |a KXP-PPN1809476496 |e 4162670838 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"physDesc":[{"extent":"14 S."}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.3390/cancers14102479"],"eki":["1809476496"]},"relHost":[{"note":["Gesehen am 27.05.2020"],"part":{"issue":"10","extent":"14","pages":"1-14","year":"2022","volume":"14","text":"14(2022), 10, Artikel-ID 2479, Seite 1-14"},"id":{"zdb":["2527080-1"],"issn":["2072-6694"],"eki":["614095670"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Cancers","title":"Cancers"}],"origin":[{"dateIssuedKey":"2009","publisherPlace":"Basel","publisher":"MDPI","dateIssuedDisp":"2009-"}],"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["1.2009 -"],"language":["eng"],"recId":"614095670","disp":"Early assessment of chemotherapy response in advanced non-small cell lung cancer with circulating tumor DNACancers"}],"note":["Published: 18 May 2022","This article belongs to the Special Issue Cell-Free DNA as Prognostic and Predictive Biomarker in Solid Cancers","Gesehen am 08.07.2022"],"person":[{"role":"aut","given":"Stephanie","display":"Yaung, Stephanie","family":"Yaung"},{"role":"aut","family":"Woestmann","display":"Woestmann, Corinna","given":"Corinna"},{"family":"Ju","display":"Ju, Christine","given":"Christine","role":"aut"},{"display":"Ma, Xiaoju Max","given":"Xiaoju Max","family":"Ma","role":"aut"},{"role":"aut","family":"Gattam","display":"Gattam, Sandeep","given":"Sandeep"},{"role":"aut","family":"Zhou","given":"Yiyong","display":"Zhou, Yiyong"},{"role":"aut","family":"Xi","display":"Xi, Liu","given":"Liu"},{"role":"aut","given":"Subrata","display":"Pal, Subrata","family":"Pal"},{"role":"aut","display":"Balasubramanyam, Aarthi","given":"Aarthi","family":"Balasubramanyam"},{"display":"Tikoo, Nalin","given":"Nalin","family":"Tikoo","role":"aut"},{"display":"Heußel, Claus Peter","given":"Claus Peter","family":"Heußel","role":"aut"},{"role":"aut","family":"Thomas","display":"Thomas, Michael","given":"Michael"},{"given":"Mark","display":"Kriegsmann, Mark","family":"Kriegsmann","role":"aut"},{"role":"aut","family":"Meister","given":"Michael","display":"Meister, Michael"},{"role":"aut","given":"Marc","display":"Schneider, Marc","family":"Schneider"},{"display":"Herth, Felix","given":"Felix","family":"Herth","role":"aut"},{"role":"aut","display":"Wehnl, Birgit","given":"Birgit","family":"Wehnl"},{"display":"Diehn, Maximilian","given":"Maximilian","family":"Diehn","role":"aut"},{"role":"aut","family":"Alizadeh","given":"Ash A.","display":"Alizadeh, Ash A."},{"role":"aut","display":"Palma, John F.","given":"John F.","family":"Palma"},{"family":"Muley","given":"Thomas","display":"Muley, Thomas","role":"aut"}],"recId":"1809476496","name":{"displayForm":["Stephanie J. Yaung, Corinna Woestmann, Christine Ju, Xiaoju Max Ma, Sandeep Gattam, Yiyong Zhou, Liu Xi, Subrata Pal, Aarthi Balasubramanyam, Nalin Tikoo, Claus Peter Heussel, Michael Thomas, Mark Kriegsmann, Michael Meister, Marc A. Schneider, Felix J. Herth, Birgit Wehnl, Maximilian Diehn, Ash A. Alizadeh, John F. Palma and Thomas Muley"]},"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"2022"}],"language":["eng"],"title":[{"title":"Early assessment of chemotherapy response in advanced non-small cell lung cancer with circulating tumor DNA","title_sort":"Early assessment of chemotherapy response in advanced non-small cell lung cancer with circulating tumor DNA"}]} | ||
| SRT | |a YAUNGSTEPHEARLYASSES2022 | ||